Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/emsSCfbwocfDydsxhjjX

  ADVERTISEMENT  
March 7, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  ADVERTISEMENT  
Clinical Research: Understanding the Methodology Toolbox
Clinical Research: Understanding the Methodology Toolbox compiles articles of evidence-based research for use as an educational resource for those involved in clinical research, healthcare professionals and trainees in transfusion medicine and other medical specialties. Now in the AABB Marketplace.

  Science & Health 
  • Research on synthetic heparin faces limited funding
    University of North Carolina researchers who are working on a synthetic version of the anticoagulant heparin expressed concern that federal budget cuts may hinder full development of the drug. Lead scientist Jian Liu said a breakthrough is at hand, but some members of the research team may have to go. CNNMoney (3/6) LinkedInFacebookTwitterEmail this Story
 
  Emerging Trends 
  Industry News & Practice 
The Buzz(CORPORATE ANNOUNCEMENTS)

ISBT 128 Cell Therapy Update
STEMSOFT Software Inc. and Digi-Trax® Corporation are pleased to announce the certified integration of the HemaTrax®-CT labeling system into StemLab’s leading cellular therapy software to produce ISBT 128 compliant, on demand CT labels. Learn more about how we can help you adopt ISBT 128 in your cell therapy facility today.


  Government & Regulatory 
  • Sequestration to cut Medicare EHR payments
    Sequestration will reduce the EHR incentive payments going to Medicare providers by 2%, starting April 1. On average, the cuts would cost Medicare-only hospitals, which are averaging $1.87 million in incentive payments, about $37,500, and physicians receiving Medicare EHR incentives would lose a few hundred dollars on average. Medicaid EHR incentives will not be affected. Modern Healthcare (subscription required) (3/5) LinkedInFacebookTwitterEmail this Story
  • ICD-10 transition to move forward, CMS says
    CMS announced that the shift to ICD-10 codes will continue without additional delays, meaning providers must begin using the new codes Oct. 1, 2014. "Many in the health industry are under way with the necessary system changes to transition from ICD-9 to ICD-10. Halting this progress midstream would be costly, burdensome, and would eliminate the impending benefits of these investments," said acting CMS Administrator Marilyn Tavenner. American Medical News (free content) (3/4) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Summary, presentations from Cell Therapy-FDA Liaison meeting now available online
    A summary of the November 2012 Cell Therapy FDA Liaison Committee meeting, along with corresponding speaker presentations, has been posted on the AABB website. The first session identified the key issue of reconciling ISBT 128 labeling with the required labeling for FDA-approved cellular therapy products. The second session focused on the unique biology of origin for mesenchymal stem cells, and the final session highlighted the expansion of cellular therapy science and practice. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Reference Lab TechnologistAmerican Red Cross Blood ServicesUS - CA - Oakland
Cord Blood Laboratory ManagerPuget Sound Blood CenterUS - WA - Seattle
IRL Clinical Lab ManagerBlood Systems LaboratoriesUS - AZ - Tempe
Assistant Medical DirectorLifeStreamUS - CA
Director, Technical ServicesUnited Blood ServicesUS - NV - Reno
Supervisor of Blood Donor ServicesBaystate HealthUS - MA - Springfield
Click here to view more job listings.

  SmartQuote 
Scientific progress makes moral progress a necessity; for if man's power is increased, the checks that restrain him from abusing it must be strengthened."
--Anne Louise Germaine de Staël,
Swiss author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information